1.InGeneron

InGeneron believes that evidence-based regenerative therapy will redefine the health care experience. Our system is designed to enable doctors to heal patients safely and quickly by unlocking and using the healing potential of their own regenerative cells.

Founded in 2006, we are a Houston-headquartered, privately held company that was formed to innovate cell-based technologies for health care and life science research. The work of our scientists and doctors in the field of stem and regenerative cell research has enabled us to develop a regenerative cell therapy products platform for multiple potential applications. This work has yielded numerous peer-reviewed publications and studies on the use of autologous.

Products

Medical Products

Animal Health Products

Contact no:+1 713-440-9900

Address:8205 El Rio St, Houston, TX 77054, United States

Website:https://ingeneron.com/

2.Johnson & Johnson Innovation JLABS @ TMC

Johnson & Johnson Innovation – JLABS (JLABS) is a global network of open innovation ecosystems, enabling and empowering innovators across a broad healthcare spectrum including pharmaceutical, medical device, consumer and health tech sectors to create and accelerate the delivery of life-saving, life-enhancing health and wellness solutions to patients around the world. JLABS achieves this by providing the optimal environment for emerging companies to catalyze growth and optimize their research and development by opening them to vital industry connections, delivering entrepreneurial programs and providing a capital-efficient, flexible platform where they can transform the scientific discoveries of today into the breakthrough healthcare solutions of tomorrow.

Contact no:+1 346-772-0300

Address:2450 Holcombe Blvd suit j, Houston, TX 77021, United States

Website:https://jlabs.jnjinnovation.com/locations/jlabs-tmc

3.Tvardi Therapeutics

Tvardi Therapeutics is a clinical stage, private biotechnology company developing a new class of breakthrough medicines for diverse cancers, chronic inflammatory diseases and fibrotic diseases. Founded in 2017 and based in Houston, Texas, the company is led by experienced entrepreneurs, innovative scientists and dedicated physicians.

Tvardi is focused on the development of inhibitors of STAT3, a key signaling molecule positioned at the intersection of many pathways controlling gene networks integral to the survival and immune sequestration of cancer cells as well as to the pathogenesis of many inflammatory and fibrotic conditions.

-Pipeline

TTI-102 is a next generation orally bioavailable, small molecule STAT3 inhibitor that is structurally related to, yet chemically distinct from TTI-101. TTI-102 has demonstrated key characteristics for clinical use including tolerability, bioavailability, and potency in preclinical studies.

Address: 7000 Fannin St #1960m, Houston, TX 77019, United States

Website:https://tvarditherapeutics.com/

4.Celltex Therapeutics Corporation

Celltex has helped past clients find improvements in their neurological, autoimmune and degenerative conditions. 

Celltex’s proprietary stem cell processing and banking methods ensure the genetic integrity and uniformity of an individual’s cells in quantities never before possible and in the quantities necessary for therapeutic applications. An individual can then use his or her banked stem cells for regenerative therapy through infusions or injections performed by a licensed physician in Cancun.

Celltex Therapeutics Corporation was founded in 2011 by David Eller and Dr. Stanley Jones, a nationally known spine surgeon, to spearhead breakthroughs in regenerative medicine through Mesenchymal Stem Cells (MSCs). Celltex uses proprietary technology that isolates, multiplies and stores autologous, adult, adipose (fat tissue)-derived MSCs to be used for regenerative therapy in a number of conditions, including vascular, autoimmune and degenerative diseases.

Contact no:: +1 713-590-1000

Address: 2401 Fountain View Dr # 416, Houston, TX 77057, United States

Website:https://celltexbank.com/

5.Nanospectra Biosciences Inc

Nanospectra Biosciences is a medical device company pioneering a patient-centric use of nanomedicine for selective thermal ablation.Nanospectra’s proprietary AuroLase® Therapy utilizes ‘optical tunability’ for a new class of nanoparticles, called AuroShells®. These nanoshells convert light into heat and thermally destroy solid tumors without damaging adjacent healthy tissue.AuroLase is the first and only ultra-focal tissue ablation therapy designed to maximize treatment efficacy while minimizing side effects typically associated with surgery, radiation, and traditional focal therapies.

Services

AUROLASE THERAPY

AuroShells: Tumor-Specific Targeting

NORMAL VESSEL ENDOTHELIUM

AuroLase for the Ablation  of Prostate Cancer Tissue

Contact no:+1 713-842-2720

Address: 8285 El Rio St # 150, Houston, TX 77054, United States

Website:https://nanospectra.com/

6.Academy Biomedical Company, Inc.

Academy Bio-Medical Company has been in the business of supplying high quality antibodies at affordable prices for the cardiovascular and atherosclerosis research community since 1995. We are proud to offer the scientific community our antibodies and reagents devoted to research in the area of lipoproteins, apolipoproteins, and their oxidatively modified products.

PRODUCT INFORMATION 

Apolipoprotein Information

Oxidized Protein Information

Contact no:+1 713-675-4040

Address:1417 Kress St, Houston, TX 77020, United States

Website:https://www.academybiomed.com/

7.MultiVir

Mr. Wells has served as Chairman since December 2014 and has been a member of our board of directors since inception. Since 2000, Mr. Wells has served as President of Pope Asset Management, LLC, a registered investment advisor offering financial asset management services to high net worth investors. Mr. Wells is the founder and primary portfolio manager for Pope Asset Management, LLC. Mr. Wells previously worked in the private wealth management division of Goldman Sachs & Co. from 1985 to 2000. Mr. Wells received a B.A. in Economics from the University of Mississippi and an M.B.A. from the Amos Tuck Business School at Dartmouth College.

Our Clinical Trials

Patients and Families

Medical Professionals

Multiple Cancers

Small Cell Lung Cancer

Melanoma

Contact no: +1 832-431-3555

Address:410 Pierce St #325, Houston, TX 77002, United States

Website:https://multivir.com/

8.Immatics US

Immatics combines the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors with the goal of enabling a robust and specific T cell response against these targets. This deep know-how is the foundation for our pipeline of Adoptive Cell Therapies and TCR Bispecifics as well as our partnerships with global leaders in the pharmaceutical industry. We are committed to delivering the power of T cells and to unlocking new avenues for patients in their fight against cancer.

Product

Pipeline

Immatics is developing targeted immunotherapies with an emphasis on treating solid tumors through two distinct therapeutic modalities: Adoptive Cell Therapies (ACT) and antibody-like TCR Bispecifics (TCER®). Immatics’ wholly owned pipeline is comprised of seven therapeutic programs, of which three are in clinical trials and four are in preclinical development.

Contact no:+1 346-204-5400

Address:2130 W Holcombe Blvd #900, Houston, TX 77030, United States

Website:https://immatics.com/

9.Synthecon Inc

Our mission is to be the unrivaled leader of 3D cell culture technology by innovating and exploring the potential of the rotary cell culture system as it applies to tissue engineering, stem cell culture, tumor spheroid formation, host- pathogen studies and more.

Synthecon, Incorporated is a biotechnology company that specializes in the design and manufacture of 3D cell culture systems. Synthecon’s rotating bioreactors have applications in various fields of cell culture and tissue engineering, the latest of which is stem cell culture for regenerative medicine. Marketed under the trademark name Rotary Cell Culture SystemsTM(RCCS), Synthecon’s bioreactors have been recognized by over 500 peer-reviewed scientific publications as a superior technology for growing 3D tissue analogs.

Products

RCCS 3D CELL CULTURE SYSTEMS

STEM CELL CULTURE SYSTEMS

PERFUSION BIOREACTORS

CUSTOM DESIGNED BIOREACTORS

NANOBIOMATRIX SCAFFOLDS

BIOSTRUCTURE MATRIX SCAFFOLDS

Contact no: +1 713-741-2582

Address:8977 Interchange Dr, Houston, TX 77054, United States

Website:https://synthecon.com/pages/home.asp

10.Drylet, LLC

Drylet was founded on the principle of helping nature. We are a bioremediation technology company whose proprietary biocatalysts optimize biological processes in wastewater and waste-to-energy facilities in particular. Outcomes include solids reduction up to 70% in wastewater treatment plants and animal production facilities, and up to 30+% biogas production boost in biodigesters .Our cost-effective and zero-footprint, zero-CAPEX solution to biosolids accumulation improves operations, reduces environmental impacts, and streamlines regulatory compliance.

PRODUCTS

Aqua Assist Wastewater

ManureMagic®

Bio React AD

Bio React Septic

Aqua Assist Marine

Bio React Drain

MB Bio

Contact no:+1 346-980-9570

Address: 8300 Farm to Market 1960 Rd W #450, Houston, TX 77070, United States

Website:https://www.drylet.com/